drugset / Trial / NCT00606515
Pharmacokinetics Study of Liposomal Paclitaxel in Humans
Phase 4
Completed
16 enrolled
Shandong Luye Pharmaceutical Co., Ltd.
Nanjing Sike Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupOpen-label
Summary
The purpose of this study is to determine whether there is any difference of the pharmacokinetics of two taxane formulations, paclitaxel injection and liposomal paclitaxel in Chinese cancer patients with solid tumors.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |